Yifei Cheng
300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 21, 2026
HOXD11-NMDAR signaling drives neuroendocrine prostate cancer and enables potential therapeutic intervention as a target of memantine.
Journal: Cell reports
Published: December 16, 2025
Multi-omics analyses related to unfolded protein response in prostate cancer implicate pro-tumor role of IFRD1.
Journal: Frontiers in immunology
Published: November 11, 2025
A conserved eIF1A+ luminal cell-centered hypoxic and "cold" tumor microenvironment promotes pan-subtype prostate cancer progression.
Journal: Cell reports. Medicine
Published: August 26, 2025
Author Correction: Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer.
Journal: Nature aging
Published: May 12, 2025
OPRK1 drives SLC9A3R1 progression to neuroendocrine prostate cancer.
Journal: Cell death & disease
Published: January 30, 2025
Methylation-induced silencing of AZGP1 enhances prostate cancer metastasis by stimulating tumoral glycolysis.
Journal: Cellular & molecular biology letters
Published: January 19, 2025
Genetic variation of circHIBADH enhances prostate cancer risk through regulating HNRNPA1-related RNA splicing.
Journal: Journal of biomedical research
Published: May 29, 2024
A EPCAM Pathogenic Variant in Familial Lynch Syndrome-Associated Colon Cancer: Insights into Genetic Basis and Tumor Microenvironment Characteristics.
Journal: Phenomics (Cham, Switzerland)
Published: April 16, 2024
Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer.
Journal: Nature aging
Published: March 27, 2024
piRNA PROPER Suppresses DUSP1 Translation by Targeting N6-Methyladenosine-Mediated RNA Circularization to Promote Oncogenesis of Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 21, 2024
Genetic variant in a BaP-activated super-enhancer increases prostate cancer risk by promoting AhR-mediated FAM227A expression.
Journal: Journal of biomedical research
Published: February 27, 2024
Last Updated: 09/26/2026